language_icon
EN
HI

Sai Parenteral's Share price

SAIPARENT

512.25

26.35 (5.42%)
NSE
BSE
Last updated on 1 Jun, 2026 | 15:59 IST
Today's High

543.20

Today's Low

497.05

52 Week Low

400.00

52 Week High

543.20

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Sai Parenteral's Chart

Sai Parenteral's Share Key Metrics

Volume
17.70 L
Market Cap
2263.08 CR
LTQ@LTP
100@512.25
ATP
517.81
Var Margin
12.5 %
Circuit Range
388.75-583.05
Delivery %
67.86 %
Value
91.63 CR
ASM/GSM
No
Market Lot
1

Summary

Sai Parenteral's share price is ₹512.25 as of 1 Jun, 2026. The stock Sai Parenteral's intraday movement has stayed between ₹497.05 and ₹543.20, while on a 52-week basis,Sai Parenteral's price 52 week high is ₹543.20 & its 52 week low is ₹400.00.
In terms of trading activity, Sai Parenteral's has recorded a volume of 1769589 shares, The Sai Parenteral's has a market cap of ₹44179231 CR. The stock’s Average Traded Price (ATP) stands at ₹517.81, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100 @ ₹512.25.
Sai Parenteral's operates within a circuit range of ₹388.75 – ₹583.05, with a Value of ₹91.63 CR. The Delivery Percentage for the day is 67.86%. Additionally, Sai Parenteral's currently falls under the No framework, and trades with a market lot size of 1.

Sai Parenteral's Fundamentals

View More
P/E Ratio

151.63

P/B Ratio

2.8

Div. Yield

0

Sector P/E

69.53

Sector P/B

2.99

Sec. Div. Yield

0.55

Sai Parenteral's Resistance and Support

Pivot 486.3

Resistance

First Resistance

498.6

Second Resistance

511.3

Third Resistance

523.6

Support

First Support

473.6

Second Support

461.3

Third Support

448.6

Sai Parenteral's Shareholding Pattern

View More
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

51.16%

Mutual Fund

3.81%

Insurance

2.89%

Foreign Institutional Investors

5.73%

Domestic Institutional Investors

6.16%

Retail

30.26%

Others

-0.01%

Total Promoters
MAR '26
51.16%

Sai Parenteral's Corporate Actions

DateAgenda
2026-05-23Audited Results & Others
2026-04-20Others

Sai Parenteral's News

Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

Sai Parenterals secured a USD 11 million (Rs. 104.50 crore) order from The Pill Corp, Philippines. This 10-year exclusive contract is for the supply of anti-TB products in the Philippines market.
May 28 2026 20:13:34

Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Sai Parenterals announced the audio recording of its Post Earnings (Group Conference) Call for Q4 and year ended March 31, 2026, is available. Investors can access the recording via the company's website for details on financial performance.
May 27 2026 21:10:14

Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Sai Parenterals delivered robust Q4 FY26 results, with revenue increasing 166.65% YoY to Rs.197.93 crore and net profit up 736.04% to Rs.13.25 crore. Full-year FY26 revenue grew 140.37% to Rs.380.99 crore, demonstrating strong growth momentum.
May 23 2026 20:13:24

Sai Parenterals Ltd - 544742 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 23.05.2026

Sai Parenterals reported audited FY26 consolidated revenue of ₹381.00 cr and a net profit of ₹14.26 cr. Additionally, its subsidiary acquired a 74.64% stake in Noumed Life Sciences (UK) for AUD 22 million to expand its global footprint.
May 23 2026 16:31:49

Sai Parenterals Ltd - 544742 - Board Meeting Intimation for The Notice Of Board Meeting

Sai Parenterals will hold a board meeting on May 23, 2026, to consider and approve unaudited financial results for Q3 FY26 and audited financial results for the full year FY26. The meeting will also review the limited review report and audit report.
May 19 2026 15:47:45

Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Sai Parenteral's received a monitoring agency report from India Ratings & Research confirming that there were no deviations in the utilization of IPO proceeds for the quarter ended March 31, 2026, adhering to disclosed objects.
May 13 2026 13:12:51
Read More

Sai Parenteral's Management

NamePosition
Anil Kumar KarusalaChairman & Managing Director
Vijitha GorrepatiWhole Time Director
View More

Sai Parenteral's FAQs

The Buying Price of Sai Parenteral's share is 512.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Sai Parenteral's stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sai Parenteral's, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Sai Parenteral's shares is 151.63. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Sai Parenteral's shares is 2.8. Useful to assess the stock's value relative to its book value.

To assess Sai Parenteral's’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.

The Market Cap of Sai Parenteral's is 2263.08 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Sai Parenteral's share price is 543.20 & 400.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Sai Parenteral's belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost